Transcatheter embolization of arterioportal fistulae in liver transplant recipients is restricted to symptomatic arterioportal fistulae. Angiograms of liver transplant recipients from a single university medical center were retrospectively reviewed. Hemodynamically significant arterioportal fistulae were defined as those exhibiting opacification of the main portal vein of the transplanted hepatic graft or its first order branch with or without portal venous changes by Doppler ultrasound imaging. Six arterioportal fistulae were found. Doppler ultrasound imaging detected 50% of all arterioportal fistulae and all 3 hemodynamically significant arterioportal fistulae. Three successful embolizations were performed. Follow-up (37 to 67 months) demonstrated patent hepatic arteries and no parenchymal ischemic changes with graft preservation. High-throughput arterioportal fistulae may require larger intrahepatic artery branch embolization. There is a window of opportunity for embolizing significant arterioportal fistulae before their progression to large symptomatic, high through-put arterioportal fistulae with their added risk of ischemic changes before and after embolization.

Download full-text PDF

Source
http://dx.doi.org/10.1177/1538574406294072DOI Listing

Publication Analysis

Top Keywords

arterioportal fistulae
40
liver transplant
12
transplant recipients
12
arterioportal
10
fistulae
10
fistulae liver
8
hemodynamically arterioportal
8
doppler ultrasound
8
ultrasound imaging
8
ischemic changes
8

Similar Publications

Background: Traumatic arteriovenous fistulas (AVFs) are rare entities, especially when referring to visceral arterioportal AVFs. Currently, there are no large epidemiological studies looking specifically at traumatic visceral AVFs. When traumatic AVFs have been discussed in the literature, it is in the form of case reports or case series and focused on peripheral AVFs.

View Article and Find Full Text PDF

BACKGROUND Arterioportal fistulas (APFs) are abnormal connections between the arterial and portal venous systems, leading to portal hypertension (PH) and symptoms such as gastrointestinal bleeding, splenomegaly, and hepatic pain. Symptoms typically appear by the age of 2 years in about 75% of cases. CASE REPORT A 7-year-old boy with an asymptomatic APF developed life-threatening complications following a Clostridium difficile infection.

View Article and Find Full Text PDF

Endovascular treatment of a pancreatic artery pseudoaneurysm with arterioportal fistula in chronic pancreatitis: A case report.

Radiol Case Rep

November 2024

Department of Diagnostic and Interventional Radiology, Institute of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan.

Article Synopsis
  • * An 87-year-old woman with pancreatitis experienced significant abdominal pain, and tests showed high amylase levels and severe anemia, leading to a CT scan that identified a pseudoaneurysm in her dorsal pancreatic artery.
  • * Due to her age and the high risks associated with surgery, the medical team opted for a less invasive endovascular procedure, successfully embolizing the pseudoaneurysm, which was confirmed to have resolved in a follow-up CT scan a week later.
View Article and Find Full Text PDF
Article Synopsis
  • Visceral artery pseudoaneurysms, especially in the gastroduodenal artery, are rare but can lead to severe complications like rupture, particularly in patients with chronic pancreatitis.
  • A 61-year-old man with chronic pancreatitis and other health issues was found to have a 7 cm pseudoaneurysm that was successfully treated using coil embolization after presenting with abdominal pain and fevers.
  • This case emphasizes the need for quick diagnosis and treatment of GDA pseudoaneurysms and shows that endovascular therapies can effectively enhance outcomes in complex cases linked to chronic pancreatitis.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!